Ahammune

Pune, India · Founded 2016 · Privately Held (backing)

Developer of novel drugs designed to treat the early stages of Vitiligo. Ahammune is based in Pune, India and was founded in 2016. Its last known valuation is $24.4 million. It has raised $7.2 million.

Last price · $/share
—
Implied valuation
$24.4M
Total raised
$7.2M
Last round
—
What is Ahammune worth?
$24.4Mlast known valuation
Free account
More of Ahammune with a free account
  • ·The complete investor list: 17 names
  • ·Watch Ahammune: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ahammune funding history

No rounds on record

No funding rounds for Ahammune are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Ahammune valuation

Ahammune's last known valuation is $24.4 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Ahammune's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Ahammune, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Ahammune

What is Ahammune worth?
Ahammune's last known valuation is $24.4M.
How much has Ahammune raised?
Ahammune has raised $7.2M in total funding across its recorded rounds.